Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

被引：0
作者：
Hisaharu Shikata
Yoshihiro Yakushijin
Jun Yamanouchi
Taichi Azuma
Masaki Yasukawa
机构：
[1] Ehime University Graduate School of Medicine,Department of Bioregulatory Medicine, Ehime University Hospital
[2] Ehime University Graduate School of Medicine,Cancer Center, Ehime University Hospital
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Hematological nadir; Febrile neutropenia (FN); G-CSF prophylaxis; R-CHOP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 49 条
  • [21] Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2)
    Masahiro Yokoyama
    Yoshiharu Kusano
    Anna Nishihara
    Norihito Inoue
    Noriko Nishimura
    Yuko Mishima
    Yasuhito Terui
    Tomoyuki Nukada
    Takanobu Nomura
    Kiyohiko Hatake
    Supportive Care in Cancer, 2020, 28 : 571 - 579
  • [22] Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin's lymphoma in a developing country?
    Ruiz-Delgado, Guillermo J.
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz C.
    Cantu-Rodriguez, Olga G.
    Alarcon Urdaneta, Carlos
    Rodriguez-Morales, Uxmal
    Calderon-Garcia, Jackeline
    Fernandez-Vargas, Omar
    Montes-Montiel, Maryel
    Sanchez-Cardenas, Nica
    Ruiz-Argueelles, Guillermo J.
    HEMATOLOGY, 2012, 17 (04) : 193 - 197
  • [23] Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
    Masahiro Yokoyama
    Yoshiharu Kusano
    Norihito Inoue
    Noriko Nishimura
    Yuko Mishima
    Tomoyuki Nukada
    Kiyohiko Hatake
    Yasuhito Terui
    BMC Cancer, 21
  • [24] Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
    Yokoyama, Masahiro
    Kusano, Yoshiharu
    Inoue, Norihito
    Nishimura, Noriko
    Mishima, Yuko
    Nukada, Tomoyuki
    Hatake, Kiyohiko
    Terui, Yasuhito
    BMC CANCER, 2021, 21 (01)
  • [25] Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP
    Green, Tina M.
    Jensen, Andreas K.
    Holst, Rene
    Falgreen, Steffen
    Bogsted, Martin
    de Stricker, Karin
    Plesner, Torben
    Mourits-Andersen, Torben
    Frederiksen, Mikael
    Johnsen, Hans E.
    Pedersen, Lars M.
    Moller, Michael B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (06) : 876 - 886
  • [26] Increased CD59 protein expression is associated with the outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP
    Song, Guoqi
    Cho, William C.
    Gu, Ling
    He, Bangshun
    Pan, Yuqin
    Wang, Shukui
    MEDICAL ONCOLOGY, 2014, 31 (07)
  • [27] Increased CD59 protein expression is associated with the outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP
    Guoqi Song
    William C. Cho
    Ling Gu
    Bangshun He
    Yuqin Pan
    Shukui Wang
    Medical Oncology, 2014, 31
  • [28] Effect of R-CHOP chemotherapy on liver and mediastinal blood pool 18F-FDG standardized uptake values in patients with non-Hodgkin's lymphoma
    Kaya, Bugra
    Dostbil, Zeki
    Ismailoglu, Murat
    Tasdemir, Bekir
    Sahin, Ozlem
    CLINICAL IMAGING, 2015, 39 (04) : 632 - 635
  • [29] Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Soranobu Ninomiya
    Takeshi Hara
    Hisashi Tsurumi
    Masato Hoshi
    Nobuhiro Kanemura
    Naoe Goto
    Senji Kasahara
    Masahito Shimizu
    Hiroyasu Ito
    Kuniaki Saito
    Yoshinobu Hirose
    Tetsuya Yamada
    Takeshi Takahashi
    Mitsuru Seishima
    Tsuyoshi Takami
    Hisataka Moriwaki
    Annals of Hematology, 2011, 90 : 409 - 416
  • [30] Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Ninomiya, Soranobu
    Hara, Takeshi
    Tsurumi, Hisashi
    Hoshi, Masato
    Kanemura, Nobuhiro
    Goto, Naoe
    Kasahara, Senji
    Shimizu, Masahito
    Ito, Hiroyasu
    Saito, Kuniaki
    Hirose, Yoshinobu
    Yamada, Tetsuya
    Takahashi, Takeshi
    Seishima, Mitsuru
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    ANNALS OF HEMATOLOGY, 2011, 90 (04) : 409 - 416
12345